Prevalence and Management of Gastrointestinal Complications in Lung Transplant Patients: MITOS Study Group

Transplantation Proceedings

Volumn 39, Issue 7, 2007, Pages 2409-2412

  Bravo, C ^a   Gispert, P ^a   Borro, J M ^b   de la Torre, M ^b   Cifrian Martinez J M ^c   Fernandez Rozas S ^c   Zurbano Goni F ^c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL JUAN CANALEJO   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ABDOMINAL PAIN; ADULT; ANOREXIA; ARTICLE; COMBINATION CHEMOTHERAPY; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DIGESTIVE SYSTEM PERFORATION; DISEASE SEVERITY; DYSPEPSIA; EMPHYSEMA; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEARTBURN; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SPAIN; VOMITING;

ADOLESCENT; ADULT; AGED; CADAVER; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL DISEASES; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREVALENCE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SPAIN; TISSUE DONORS;

EID: 34548802421     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.07.054     Document Type: Article

References (16)

1. Helderman J.H., and Goral S. Gastrointestinal complications of transplant immunosuppression. Review. Am J Nephrol 13 (2002) 277
2. Rubin R.H. Gastrointestinal infectious disease complications following transplantation and their differentiation from immunosuppresant-induced gastrointestinal toxicities. Clin Transplant 15 suppl 4 (2001) 11
3. Hardinger K.L., Brennan D.C., Lowel J., et al. Long term outcome of gastrointestinal complications in renal transplant patients treated with MMF mofetil. Clin Transplant Int 17 (2004) 609
4. Helderman J.H. Prophylaxis and treatment og gastrointestinal complications after transplantation. Clin Transplant 15 Suppl 4 (2001) 29
5. Tierce J.C., Porterfield-Baxa J., Petrilla A.A., et al. Impact of mycophenolate mofetil (MMF) related gastrointestinal complications and MMF dose alterations on transplant outcomes and health care costs in renal transplant recipients. Clin Transplant 19 (2005) 779
6. Massari P., Duro-Garcia V., Giron F., et al. Safety assesment of the conversión from mycophenolate mofetil to enteric coated mycophenolate sodiun in stable renal transplant recipients. Transplant Proc 36 (2005) 916
7. Nasahm B., Suwelack B., Ivens K., et al. Conversión to enteric coated mycophenolate sodium from various doss of mycophenolate mofetil: results of a prospective international multicenter trial in maintenance renal transplant patients receiving cyclosporine. Transplant Proc 38 (2006) 2856
8. Budde K., Glander P., Diekmann F., et al. Review of immunosuppresant enteric coated mycophenolate sodium. Expert Opin Pharmacother 5 (2004) 1333
9. Hoekstra H.J., Hawkins K., De Boer W.J., et al. Gastrointestinal complications in lung transplant survivors that require surgical intervention. Br J Surg 88 (2001) 433
10. Sterling R.K. Focused clinical review. Gastrointestinal complications in liver transplant recipients. Med Gen Med 3 1 (2001)
11. Caraceni P., Fagiuoli S., Wright H.I., et al. Gastrointestinal complications of liver transplantation. Ital J Gastroenterol 27 (1995) 29
12. Lubetkin E.I., Lipson D.A., Palevsky H.I., et al. GI complications after orthotopic lung transplantation. Am J Gastroenterol 91 (1996) 2382
13. Pelletier R.P., Akin B., Henry M.L., et al. The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation. Clin Transplant 17 (2003) 200
14. Bunnapradist S., Lentine K.L., Burroughs T.E., et al. Mycophenolate mofetil dose reduction and discontinuation after gastrointestinal complications are associated with renal transplant graft failure. Transplantation 82 (2006) 102
15. Dumortier J., Gagnieu M.C., Salandre J., et al. Conversion from mycophenolate mofetil to enteric coated mycophenolate sodium in liver transplant patients presenting gastrointestinal disorders: a pilot study. Liver Transpl 12 (2006) 1342
16. Hummel M., Yohan N., Ross H., et al. Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients. Clin Transplant 21 (2007) 18